Time to overcome pretreatment HIV drug resistance

Lancet Infect Dis. 2018 Mar;18(3):239-240. doi: 10.1016/S1473-3099(17)30709-0. Epub 2017 Nov 30.

Authors

Sabine Yerly¹, Alexandra Calmy²

Affiliations

¹ Laboratory of Virology, AIDS Unit, Division of Infectious Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva 1211, Switzerland. Electronic address: sabine.yerly@hcuge.ch.
² Laboratory of Virology, AIDS Unit, Division of Infectious Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva 1211, Switzerland.

PMID: 29198912
DOI: 10.1016/S1473-3099(17)30709-0

No abstract available

Publication types

Comment

MeSH terms

Anti-Retroviral Agents*
Drug Resistance, Viral / drug effects
HIV Infections
HIV-1 / drug effects*
Humans
Regression Analysis

Substances

Anti-Retroviral Agents